Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys
Open Access
- 7 July 2008
- journal article
- Published by Springer Nature in Psychopharmacology
- Vol. 202 (1-3) , 505-519
- https://doi.org/10.1007/s00213-008-1250-4
Abstract
Poor cognitive control, including reversal learning deficits, has been reported in children with attention deficit hyperactivity disorder, in stimulant-dependent humans, and in animal models of these disorders; these conditions have each been associated with abnormal catecholaminergic function within the prefrontal cortex. In the current studies, we sought to explore how elevations in extracellular catecholamine levels, produced by pharmacological inhibition of catecholamine reuptake proteins, affect behavioral flexibility in rats and monkeys. Adult male Long–Evans rats and vervet monkeys were trained, respectively, on a four-position discrimination task or a three-choice visual discrimination task. Following systemic administration of pharmacological inhibitors of the dopamine and/or norepinephrine membrane transporters, rats and monkeys were exposed to retention or reversal of acquired discriminations. In accordance with our a priori hypothesis, we found that drugs that inhibit norepinephrine transporters, such as methylphenidate, atomoxetine, and desipramine, improved reversal performance in rats and monkeys; this was mainly due to a decrease in the number of perseverative errors. Interestingly, the mixed dopamine and norepinephrine transporters inhibitor methylphenidate, if anything, impaired performance during retention in both rats and monkeys, while administration of the selective dopamine transporter inhibitor GBR-12909 increased premature responses but did not alter reversal learning performance. Our results suggest that pharmacological inhibition of the membrane norepinephrine, but not membrane dopamine, transporter is associated with enhanced behavioral flexibility. These data, combined with earlier reports, may indicate that enhanced extracellular catecholamine levels in cortical regions, secondary to norepinephrine reuptake inhibition, improves multiple aspects of inhibitory control over responding in rats and monkeys.Keywords
This publication has 79 references indexed in Scilit:
- Unique Properties of Mesoprefrontal Neurons within a Dual Mesocorticolimbic Dopamine SystemNeuron, 2008
- The Role of Orbitofrontal Cortex in Drug Addiction: A Review of Preclinical StudiesPublished by Elsevier ,2007
- Withdrawal from cocaine self-administration produces long-lasting deficits in orbitofrontal-dependent reversal learning in ratsLearning & Memory, 2007
- Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implicationsPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2007
- Testing Computational Models of Dopamine and Noradrenaline Dysfunction in Attention Deficit/Hyperactivity DisorderNeuropsychopharmacology, 2006
- Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural controlJournal of Psychopharmacology, 2006
- Chemistry of the mind: Neurochemical modulation of prefrontal cortical functionJournal of Comparative Neurology, 2005
- Orbitofrontal cortex dysfunction in attention-deficit hyperactivity disorder revealed by reversal and extinction tasksNeuroReport, 2002
- Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in manNeuropsychologia, 1991
- Increased response switching, perseveration and perseverative switching following d-amphetamine in the ratPsychopharmacology, 1983